Position in PTGX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,850,958
+$227,798 QoQ
Shares Held
15,100
-1.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#149
of 341 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STRS OHIO holds $177,004,891 across 155 Biotechnology names. PTGX ranks #14 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
66,679 | $33,121,459 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,557 | $17,806,431 | |
| 3 | MRNA |
Moderna, Inc.
|
209,874 | $14,697,476 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
299,838 | $10,611,266 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
54,428 | $10,193,275 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,364 | $10,043,564 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
38,166 | $3,026,182 | |
| 8 | EXEL |
Exelixis, Inc.
|
52,093 | $2,834,380 |
All Filings in PTGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,850,958 | 15,100 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,623,160 | 15,400 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,388,706 | 15,900 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,182,454 | 17,800 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,083,292 | 19,600 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $918,840 | 19,000 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $907,100 | 23,500 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $967,500 | 21,500 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $862,785 | 24,900 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $54,967 | 1,900 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $55,032 | 2,400 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $200,160 | 12,000 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $654,594 | 23,700 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $655,500 | 28,500 | Shares | Sole | 2023-08-02 | |
| 2022-12-31 | $166,923 | 15,300 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $128,979 | 15,300 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $121,023 | 15,300 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $300,736 | 12,700 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $451,440 | 13,200 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $233,904 | 13,200 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $394,944 | 8,800 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $259,000 | 10,000 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $201,600 | 10,000 | Shares | Sole | 2021-01-25 | |
| 2020-06-30 | $349,668 | 19,800 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $124,256 | 17,600 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||